Related references
Note: Only part of the references are listed.Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Kabsoo Shin et al.
SCIENTIFIC REPORTS (2023)
Association of PD-1/PD-L1 expression and Epstein--Barr virus infection in patients with invasive breast cancer
Wei-tong Zhang et al.
DIAGNOSTIC PATHOLOGY (2022)
Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
Hangzhi Wei et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)
Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma
Tadashi Shiraishi et al.
ONCOLOGY (2021)
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
So Yeon Oh et al.
SCIENTIFIC REPORTS (2021)
USE OF THE COMBINED POSITIVE SCORE (CPS) WITH THE COMPANION DIAGNOSTIC PD-L1 IHC 22C3 PHARMDX PROVIDES PRECISE EVALUATION OF PD-L1 EXPRESSION ACROSS MULTIPLE TUMOR INDICATIONS AND CUTOFFS
Francisco Ponce et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Higher postoperative plasma EV PD-L1 predicts poor survival in patients with gastric cancer
Gaopeng Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
Yushi Imai et al.
ONCOLOGY LETTERS (2020)
Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas
Kunihiro Asanuma et al.
SCIENTIFIC REPORTS (2020)
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
Bo Gong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
A multi-sample approach increases the accuracy of transcript assembly
Li Song et al.
NATURE COMMUNICATIONS (2019)
Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression
Tsunehiko Shigemori et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer
Kousaku Mimura et al.
CANCER SCIENCE (2018)
Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
Masaaki Ito et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Robert Brody et al.
LUNG CANCER (2017)
Development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors with the immunohistochemistry assay PD-L1 IHC 22C3 pharmDx.
Karina Kulangara et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
A protein and mRNA expression-based classification of gastric cancer
Namrata Setia et al.
MODERN PATHOLOGY (2016)
The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients
Minghui Zhang et al.
SCIENTIFIC REPORTS (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
PD-L1 and Survival in Solid Tumors: A Meta-Analysis
Pin Wu et al.
PLOS ONE (2015)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
Zonglin Chen et al.
PLOS ONE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines
Yongjing Chen et al.
CYTOKINE (2011)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Laboratory assays for Epstein-Barr virus-related disease
Margaret L. Gulley et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data
AR Abbas et al.
GENES AND IMMUNITY (2005)
Share Paper
